US Stock MarketDetailed Quotes

ENZN ENZON PHARMACEUTICALS INC

Watchlist
  • 0.150000
  • -0.006300-4.03%
15min DelayClose Sep 6 16:00 ET
11.13MMarket Cap30.00P/E (TTM)

ENZON PHARMACEUTICALS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
26K
0
0
0
0
0
0
-96.29%26K
-10.34%26K
0
Operating revenue
--26K
--0
--0
--0
--0
--0
--0
-96.29%26K
-10.34%26K
--0
Cost of revenue
Gross profit
Operating expense
10.38%351K
14.39%326K
-1.32%1.04M
-8.86%216K
1.81%225K
4.95%318K
-4.04%285K
-9.57%1.06M
-8.85%237K
-3.07%221K
Selling and administrative expenses
10.38%351K
14.39%326K
-1.32%1.04M
-8.86%216K
1.81%225K
4.95%318K
-4.04%285K
-9.57%1.06M
-8.85%237K
-3.07%221K
-General and administrative expense
10.38%351K
14.39%326K
-1.32%1.04M
-8.86%216K
1.81%225K
4.95%318K
-4.04%285K
-9.57%1.06M
-8.85%237K
-3.07%221K
Operating profit
-2.20%-325K
-14.39%-326K
-1.16%-1.04M
-2.37%-216K
-1.81%-225K
-4.95%-318K
4.04%-285K
-120.04%-1.03M
8.66%-211K
3.07%-221K
Net non-operating interest income expense
9.40%605K
44.74%647K
250.00%2.26M
84.68%639K
199.04%622K
514.44%553K
22,250.00%447K
646K
346K
208K
Non-operating interest income
9.40%605K
44.74%647K
250.00%2.26M
84.68%639K
199.04%622K
514.44%553K
22,250.00%447K
--646K
--346K
--208K
Other net income (expense)
Income before tax
19.15%280K
98.15%321K
415.28%1.22M
213.33%423K
3,153.85%397K
210.33%235K
154.92%162K
16.45%-386K
158.70%135K
94.25%-13K
Income tax
-92.31%4K
102.86%1K
22.00%-156K
-25.76%-249K
3,700.00%76K
52K
-775.00%-35K
-2,957.14%-200K
-4,060.00%-198K
2K
Net income
50.82%276K
62.44%320K
838.17%1.37M
101.80%672K
2,240.00%321K
185.92%183K
167.70%197K
60.34%-186K
241.70%333K
93.36%-15K
Net income continuous Operations
50.82%276K
62.44%320K
838.17%1.37M
101.80%672K
2,240.00%321K
185.92%183K
167.70%197K
60.34%-186K
241.70%333K
93.36%-15K
Minority interest income
Net income attributable to the parent company
50.82%276K
62.44%320K
838.17%1.37M
101.80%672K
2,240.00%321K
185.92%183K
167.70%197K
60.34%-186K
241.70%333K
93.36%-15K
Preferred stock dividends
0.00%531K
0.00%531K
0.00%1.28M
0.00%-318K
0.00%531K
0.00%531K
0.00%531K
-36.97%1.28M
-162.97%-318K
4.94%531K
Other preferred stock dividends
Net income attributable to common stockholders
26.72%-255K
36.83%-211K
106.71%98K
52.07%990K
61.54%-210K
53.23%-348K
59.37%-334K
41.37%-1.46M
187.97%651K
25.41%-546K
Basic earnings per share
26.72%-0.0034
36.82%-0.0028
106.60%0.0013
13.20%0.0113
71.70%-0.0028
53.11%-0.0047
55.00%-0.0045
33.33%-0.02
200.00%0.01
0.00%-0.01
Diluted earnings per share
26.72%-0.0034
36.82%-0.0028
106.60%0.0013
13.20%0.0113
71.70%-0.0028
53.11%-0.0047
59.37%-0.0045
33.33%-0.02
200.00%0.01
0.00%-0.01
Dividend per share
0
0
0
0
0
0
0
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 26K000000-96.29%26K-10.34%26K0
Operating revenue --26K--0--0--0--0--0--0-96.29%26K-10.34%26K--0
Cost of revenue
Gross profit
Operating expense 10.38%351K14.39%326K-1.32%1.04M-8.86%216K1.81%225K4.95%318K-4.04%285K-9.57%1.06M-8.85%237K-3.07%221K
Selling and administrative expenses 10.38%351K14.39%326K-1.32%1.04M-8.86%216K1.81%225K4.95%318K-4.04%285K-9.57%1.06M-8.85%237K-3.07%221K
-General and administrative expense 10.38%351K14.39%326K-1.32%1.04M-8.86%216K1.81%225K4.95%318K-4.04%285K-9.57%1.06M-8.85%237K-3.07%221K
Operating profit -2.20%-325K-14.39%-326K-1.16%-1.04M-2.37%-216K-1.81%-225K-4.95%-318K4.04%-285K-120.04%-1.03M8.66%-211K3.07%-221K
Net non-operating interest income expense 9.40%605K44.74%647K250.00%2.26M84.68%639K199.04%622K514.44%553K22,250.00%447K646K346K208K
Non-operating interest income 9.40%605K44.74%647K250.00%2.26M84.68%639K199.04%622K514.44%553K22,250.00%447K--646K--346K--208K
Other net income (expense)
Income before tax 19.15%280K98.15%321K415.28%1.22M213.33%423K3,153.85%397K210.33%235K154.92%162K16.45%-386K158.70%135K94.25%-13K
Income tax -92.31%4K102.86%1K22.00%-156K-25.76%-249K3,700.00%76K52K-775.00%-35K-2,957.14%-200K-4,060.00%-198K2K
Net income 50.82%276K62.44%320K838.17%1.37M101.80%672K2,240.00%321K185.92%183K167.70%197K60.34%-186K241.70%333K93.36%-15K
Net income continuous Operations 50.82%276K62.44%320K838.17%1.37M101.80%672K2,240.00%321K185.92%183K167.70%197K60.34%-186K241.70%333K93.36%-15K
Minority interest income
Net income attributable to the parent company 50.82%276K62.44%320K838.17%1.37M101.80%672K2,240.00%321K185.92%183K167.70%197K60.34%-186K241.70%333K93.36%-15K
Preferred stock dividends 0.00%531K0.00%531K0.00%1.28M0.00%-318K0.00%531K0.00%531K0.00%531K-36.97%1.28M-162.97%-318K4.94%531K
Other preferred stock dividends
Net income attributable to common stockholders 26.72%-255K36.83%-211K106.71%98K52.07%990K61.54%-210K53.23%-348K59.37%-334K41.37%-1.46M187.97%651K25.41%-546K
Basic earnings per share 26.72%-0.003436.82%-0.0028106.60%0.001313.20%0.011371.70%-0.002853.11%-0.004755.00%-0.004533.33%-0.02200.00%0.010.00%-0.01
Diluted earnings per share 26.72%-0.003436.82%-0.0028106.60%0.001313.20%0.011371.70%-0.002853.11%-0.004759.37%-0.004533.33%-0.02200.00%0.010.00%-0.01
Dividend per share 0000000000
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg